SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 33 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $93,078 | -24.1% | 133,256 | -2.2% | 0.00% | – |
Q4 2022 | $122,671 | -86.6% | 136,300 | -10.4% | 0.00% | – |
Q3 2022 | $913,000 | +60.7% | 152,180 | +10.9% | 0.00% | – |
Q2 2022 | $568,000 | +11.6% | 137,240 | +2.3% | 0.00% | – |
Q1 2022 | $509,000 | -25.3% | 134,131 | -11.3% | 0.00% | – |
Q4 2021 | $681,000 | -3.0% | 151,253 | +0.4% | 0.00% | – |
Q3 2021 | $702,000 | -20.6% | 150,706 | +20.2% | 0.00% | – |
Q2 2021 | $884,000 | -74.4% | 125,374 | -78.5% | 0.00% | – |
Q1 2021 | $3,448,000 | +30.7% | 583,519 | +1.9% | 0.00% | – |
Q4 2020 | $2,638,000 | +24.2% | 572,515 | +4.8% | 0.00% | – |
Q3 2020 | $2,124,000 | -86.6% | 546,119 | -1.0% | 0.00% | -100.0% |
Q2 2020 | $15,856,000 | +244.9% | 551,366 | +158.1% | 0.00% | – |
Q1 2020 | $4,597,000 | +42.9% | 213,612 | +30.6% | 0.00% | – |
Q4 2019 | $3,218,000 | +257.6% | 163,533 | +172.7% | 0.00% | – |
Q3 2019 | $900,000 | – | 59,970 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |